Geode Capital Management, LLC Ani Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 425,225 shares of ANIP stock, worth $24.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

425,225

Previous 407,911 4.24%

Holding current value

$24.1 Million

Previous $26 Million 2.34%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$54.33 - $65.72 $940,669 - $1.14 Million	17,314 Added 4.24%	425,225 $25.4 Million
Q2 2024 Aug 09, 2024	BUY	$58.53 - $68.82 $4.01 Million - $4.72 Million	68,547 Added 20.2%	407,911 $26 Million
Q1 2024 May 13, 2024	BUY	$54.2 - $69.69 $524,385 - $674,250	9,675 Added 2.93%	339,364 $23.5 Million
Q4 2023 Feb 13, 2024	BUY	$48.72 - $65.43 $407,688 - $547,518	8,368 Added 2.6%	329,689 $18.2 Million
Q3 2023 Nov 13, 2023	BUY	$50.28 - $64.61 $2.9 Million - $3.72 Million	57,620 Added 21.85%	321,321 $18.7 Million
Q2 2023 Aug 11, 2023	BUY	$37.29 - $53.83 $693,444 - $1 Million	18,596 Added 7.59%	263,701 $14.2 Million
Q1 2023 May 15, 2023	BUY	$37.61 - $45.72 $216,483 - $263,164	5,756 Added 2.4%	245,105 $9.74 Million
Q4 2022 Feb 13, 2023	BUY	$31.9 - $41.95 $336,768 - $442,866	10,557 Added 4.61%	239,349 $9.63 Million
Q3 2022 Nov 14, 2022	SELL	$29.83 - $38.01 $91,070 - $116,044	-3,053 Reduced 1.32%	228,792 $7.35 Million
Q2 2022 Aug 12, 2022	BUY	$23.09 - $33.46 $829,600 - $1.2 Million	35,929 Added 18.34%	231,845 $6.88 Million
Q1 2022 May 13, 2022	SELL	$26.91 - $47.15 $202,820 - $355,369	-7,537 Reduced 3.7%	195,916 $5.51 Million
Q4 2021 Feb 11, 2022	BUY	$32.97 - $56.85 $1.33 Million - $2.3 Million	40,416 Added 24.79%	203,453 $9.38 Million
Q3 2021 Nov 12, 2021	SELL	$26.48 - $35.99 $274,994 - $373,756	-10,385 Reduced 5.99%	163,037 $5.35 Million
Q2 2021 Aug 13, 2021	BUY	$31.86 - $38.6 $427,178 - $517,548	13,408 Added 8.38%	173,422 $6.08 Million
Q1 2021 May 12, 2021	BUY	$28.4 - $36.14 $556,640 - $708,344	19,600 Added 13.96%	160,014 $5.78 Million
Q4 2020 Feb 12, 2021	SELL	$23.69 - $31.47 $108,642 - $144,321	-4,586 Reduced 3.16%	140,414 $4.08 Million
Q3 2020 Nov 13, 2020	BUY	$26.38 - $33.1 $128,417 - $161,130	4,868 Added 3.47%	145,000 $4.09 Million
Q2 2020 Aug 13, 2020	BUY	$29.93 - $50.1 $115,410 - $193,185	3,856 Added 2.83%	140,132 $4.53 Million
Q1 2020 May 14, 2020	BUY	$30.35 - $67.14 $344,593 - $762,307	11,354 Added 9.09%	136,276 $5.55 Million
Q4 2019 Feb 13, 2020	BUY	$55.65 - $79.83 $452,156 - $648,618	8,125 Added 6.96%	124,922 $7.7 Million
Q3 2019 Nov 12, 2019	BUY	$64.7 - $85.39 $50,724 - $66,945	784 Added 0.68%	116,797 $8.51 Million
Q2 2019 Aug 14, 2019	BUY	$67.77 - $82.2 $681,224 - $826,274	10,052 Added 9.49%	116,013 $9.54 Million
Q1 2019 May 14, 2019	BUY	$45.83 - $70.54 $389,646 - $599,731	8,502 Added 8.72%	105,961 $7.47 Million
Q4 2018 Feb 13, 2019	BUY	$41.17 - $56.44 $116,387 - $159,555	2,827 Added 2.99%	97,459 $4.39 Million
Q3 2018 Nov 13, 2018	BUY	$52.95 - $71.34 $386,429 - $520,639	7,298 Added 8.36%	94,632 $5.35 Million
Q2 2018 Aug 14, 2018	BUY	$56.38 - $68.08 $226,873 - $273,953	4,024 Added 4.83%	87,334 $5.83 Million
Q1 2018 May 15, 2018	BUY	$56.98 - $72.41 $360,797 - $458,500	6,332 Added 8.23%	83,310 $4.85 Million
Q4 2017 Feb 13, 2018	BUY	$53.3 - $74.56 $555,919 - $777,660	10,430 Added 15.67%	76,978 $4.96 Million
Q3 2017 Nov 14, 2017	BUY	$43.46 - $52.49 $52,195 - $63,040	1,201 Added 1.84%	66,548 $3.49 Million
Q2 2017 Aug 14, 2017	BUY	N/A	65,347	65,347 $3.06 Million

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Ani Pharmaceuticals Inc Transaction History